Hyperthermic intraperitoneal chemoperfusion as a component of multimodality therapy for ovarian and primary peritoneal cancer.
Deepa MaggeLekshmi RamalingamYongli ShuaiRobert P EdwardsJames F PingpankSteven S AhrendtMatthew P HoltzmanHerbert J ZehDavid L BartlettHaroon A ChoudryPublished in: Journal of surgical oncology (2017)
Our study demonstrates promising survival data and supports the role of HIPEC in the multimodality treatment algorithm for primary or recurrent OPM and PPC. However definite indications and timing of HIPEC need to be clarified by prospective studies.